FIRM FIXED PRICENO SET ASIDE USED.
MARLEX PHARMACEUTICALS INC - NEW AWARD FOR EZETIMIBE TABLETS WITH MARLEX PHARMACEUTICALS. PERIOD OF PERFORMANCE IS APRIL 28, 2024 - APRIL 27, 2025 WITH FOUR ONE-YEAR OPTIONS
PIID: 36E79724D0019Solicitation ID: 36E79724R0004
Signed Date: Feb 13, 2026Effective Date: Apr 28, 2024
Vendor
MARLEX PHARMACEUTICALS INC
NAICS
325412
Signed Date
Feb 13, 2026
Key Details
Description
NEW AWARD FOR EZETIMIBE TABLETS WITH MARLEX PHARMACEUTICALS. PERIOD OF PERFORMANCE IS APRIL 28, 2024 - APRIL 27, 2025 WITH FOUR ONE-YEAR OPTIONS
Context & Analysis
On Feb 13, 2026, Department of Veterans Affairs to MARLEX PHARMACEUTICALS INC for new award for ezetimibe tablets with marlex pharmaceuticals. period of performance is april 28, 2024 - april 27, 2025 with four one-year options. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 3 offers received. The procurement used a NO SET ASIDE USED. set-aside.
Contractor Information
Stay Updated
Get notified about new opportunities matching your interests.